K. Tsukasaki et al., INTEGRATION PATTERNS OF HTLV-I PROVIRUS IN RELATION TO THE CLINICAL COURSE OF ATL - FREQUENT CLONAL CHANGE AT CRISIS FROM INDOLENT DISEASE, Blood, 89(3), 1997, pp. 948-956
We examined human T-lymphotropic virus type I (HTLV-I) DNA integration
in 68 patients with adult T-cell leukemia/lymphoma (ATL) by Southern
blotting using EcoRI, which does not cut within the 9 kb of the genome
and probes for pX and gag-pol region of HTLV-I. We detected defective
proviral integration as a monoclonal band of various sizes with the p
X but not with the gag-pol probe, or a monoclonal band of less than 9
kb with the pX probe, in 20 patients (29.4%). These were designated de
fective (D) type. With both probes, a single band greater than 9 kb wa
s detected in 34 (50.0%), designated complete (C) type, and two or mor
e bands greater than 9 kb, were designated multiple (M) type, in 14 (2
0.6%). Advanced age, a high LDH value, and hypercalcemia were more fre
quent in D type patients. The median survival time (MST) was 6.8, 24.4
, and 33.3 months, for D, C, and M types, respectively (log rank P = .
006). Among 52 sequentially examined patients, the HTLV-I integration
patterns changed in 4 (7.5%). In three of these four, the rearrangemen
ts of the T-cell receptor (TCR)b gene concomitantly changed, suggestin
g the appearance of a new ATL clone. Another patient had the same rear
rangement of the TCRb gene, indicating clonal evolution. The HTLV-I in
tegration pattern changed at crisis from indolent to aggressive ATL in
three patients. These findings suggested that the HTLV-I integration
patterns have clinical implications in ATL pathophysiology. In contras
t to the clonal evolution characteristic of the multistep carcinogenes
is of most human malignancies, the frequent clonal change of ATL at cr
isis is a peculiar phenomenon, probably reflecting the emergence of mu
ltiple premalignant clones in viral leukemogenesis as suggested in Eps
tein-Barr virus associated lymphomagenesis in the immunocompromised ho
st. (C) 1997 by The American Society of Hematology.